MiNK Therapeutics & Lawrence Rosen
1 shared events · Importance 3 · Last updated May 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
MiNK Therapeutics: MiNK Therapeutics is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about the safety and commercial viability of its drug candidate, DCCR. The company's stock price has significantly declined following reports of safety concerns, a patient death, and disruptions in DCCR's launch.
Lawrence Rosen: Lawrence Rosen, founding partner of Rosen Law Firm, is mentioned as a key figure in the firm's success in securities class actions.
Apr 01, 2026 · 83 articles
NEWSDESK
Explore this relationship live
Track how MiNK Therapeutics and Lawrence Rosen interact across events, view sentiment trends, and discover connected entities.
Open Dashboard